|When:||Wednesday, March 6, 2013|
12:00 PM - 1:00 PM
Ford Motor Company Engineering Design Center, ITW 1350 |
2133 Sheridan Road
Evanston, IL 60208 map it
|Audience:||- Faculty/Staff - Student - Public|
|Contact:||Debora Ann Boetcher
|Group:||McCormick-Chemical and Biological Engineering|
****** SEMINAR CANCELLED ******
Biotech Training Seminar: Wednesday, March 6th @ 12:00 noon
"(Q)SAR computational computational toxicology; Can we stop doing routine animal testing?"
R. Daniel Benz, Ph.D.
US Food and Drug Administration
Center for Drug Evaluation and Research
Office of Testing and Research
Division of Drug Safety Research
(Q)SAR Computational Toxicology Group
Robert Daniel ("Dan") Benz undertakes (quantitative) structure-activity relationship [(Q)SAR] research and prepares computational toxicology consultations predicting the toxicological and adverse human effects of chemicals of interest to CDER drug safety evaluators. Previously Dan was a Team Leader and Review Genetic Toxicologist for the Office of Premarket Approval, FDA Center for Food Safety and Applied Nutrition after serving as an Associate Scientist in the Medical Department of the Brookhaven National Laboratory. Dan received his BS in Biology from the Illinois Institute of Technology, and his PhD in Biophysics from the University of California, Berkeley.
Dr. Benz is a member of the Genetic Toxicology Association (past Board Chair and two time Board Member), Environmental Mutagen Society (current and past Council Member), Association of Government Toxicologists (past President and Council Member), Society of Toxicology, and National Capital Area Chapter of the Society of Toxicology. Dan is a co-recipient of the FDA Outstanding Intercenter Scientific Collaboration Award "for the development of a combined CDER-CFSAN toxicology database and predictive toxicology software to support the CDER-CFSAN regulatory mission and the FDA critical path initiative" (2006); and the FDA Outstanding Intercenter Scientific Collaboration Award "for facilitation of harmonized genotoxicity standards for carcinogenicity assessment FDA-wide, and creation of an expertise resource for the Centers" (2006). He has also has received the prestigious GTA Excellence in Science Award (2007); the EMS Service Award (2004); and the AGT Outstanding Service Award (1998).